ADC Bio secures investment
Funding used to enhance bioconjugation and expand to the US
26-Apr-2018 -
ADC Biotechnology, announces that it has secured £1.14 million in funding from investment managers, Downing LLP. The funds will bolster the company’s business drive for faster penetration of the main US market. The investment will also assist the development of an advanced bioconjugation method – ...
antibody-drug conjugate
bioconjugation
funding
+1